Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Virological rebound after suppression on highly active antiretroviral therapy.
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.
Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain.
Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.